EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Initial Diagnosis and Treatment of Low-Risk Gestational Trophoblastic Neoplasia

Stephanie Alimena, Kevin M Elias, Neil S Horowitz, Ross S Berkowitz

Hematology/Oncology Clinics of North America · 2024

DOI: 10.1016/j.hoc.2024.07.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2024. Verfasst von Stephanie Alimena und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer In…. Hauptthemen laut MEDLINE: Gestational Trophoblastic Disease, Methotrexate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gestational trophoblastic neoplasia (GTN) is a rare form of cancer that is treated according to the World Health Organization (WHO) risk score, which predicts responsiveness to single-agent chemotherapy. Patients with WHO risk scores ≤6 have low-risk GTN, for which cure rates near 100%. Most women with low-risk GTN will respond to single-agent chemotherapy, which is given with either methotrexate or dactinomycin, and allows women to retain their fertility. This article also discusses less common treatment paradigms including second dilation and curettage and hysterectomy, as well as the emerging role of immunotherapy in managing low-risk GTN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gestational Trophoblastic DiseaseMethotrexateHumansFemalePregnancyHysterectomyDactinomycinDisease ManagementRisk Factors

Stichwörter der Autor:innen

ChemotherapyDactinomycinGestational trophoblastic neoplasiaHysterectomyImmunotherapyLow riskMethotrexateSecond dilation and curettage

Substanzen

MethotrexateDactinomycin

Autor:innen und Institutionen

  • Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02115, USA; Harvard Medical School, Boston, Boston…

Zitieren

APA

Alimena, S., Elias, K. M., Horowitz, N. S., & Berkowitz, R. S. (2024). Initial Diagnosis and Treatment of Low-Risk Gestational Trophoblastic Neoplasia. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2024.07.005

Vancouver

Alimena S, Elias KM, Horowitz NS, Berkowitz RS. Initial Diagnosis and Treatment of Low-Risk Gestational Trophoblastic Neoplasia. Hematology/Oncology Clinics of North America. 2024. doi:10.1016/j.hoc.2024.07.005

BibTeX
@article{Alimena2024,
  author = {Alimena, Stephanie and Elias, Kevin M and Horowitz, Neil S and Berkowitz, Ross S},
  title = {Initial Diagnosis and Treatment of Low-Risk Gestational Trophoblastic Neoplasia},
  journal = {Hematology/Oncology Clinics of North America},
  year = {2024},
  doi = {10.1016/j.hoc.2024.07.005}
}
Kostenlos starten →